ConvaTec stock faces CFO transition ahead of November update
Published on 11/04/2026 at 03:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCFO succession sets next investor milestone
- Jill McConnell will take over as Convatec's chief financial officer and join the board in March 2027.
- Fiona Ryder will remain in the role through publication of the full-year results on February 23, 2027.
- Convatec has scheduled its 10-month trading update for November 18.
Convatec announced on Tuesday, November 3, that Jill McConnell will become chief financial officer designate on January 1, 2027, before taking the full CFO and board roles on March 1. The announcement was carried by TradingView News from the company statement.
Leadership transition has fixed dates
McConnell will succeed Fiona Ryder, who will remain CFO through publication of Convatec's full-year results on February 23, 2027. Ryder is due to leave the business at the end of February after supporting an orderly handover.
McConnell brings more than 25 years of finance leadership experience in healthcare and life sciences. She was most recently CFO of Fortrea and previously held senior finance roles at Labcorp and GSK, including positions connected with US pharmaceuticals and ViiV Healthcare.
November update is the next catalyst
Convatec's investor calendar lists a 10-month trading update for November 18. The company has also said that the incoming CFO will help lead Finance, Corporate Strategy and Development, Convatec Business Services and Investor Relations from March.
Global chronic-care specialist
Convatec is a global medical products and technology company focused on solutions for managing chronic conditions. Its main businesses cover Advanced Wound Care, Ostomy Care, Continence Care and Infusion Care. The company serves around 90 countries, has more than 10,000 colleagues and holds leading positions across its portfolio.
Convatec at a glance
- Company: Convatec Group Plc
- ISIN: GB00BD3VFW73
- Ticker: CTEC
- Head office: London, United Kingdom
- Core markets: Advanced Wound Care, Ostomy Care, Continence Care and Infusion Care
- Index: FTSE 100
The FTSE 100 provides the wider market backdrop for UK-listed shares.
